Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript ... The trial will enroll adults aged 65 years and older and is ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

But what about vaccines from Moderna and Novavax? Here's what we know. Australia's medicines watchdog has approved Pfizer's new COVID-19 vaccine and it's set to be available in the coming months.

The findings were based on blood samples collected from 50 COVID-19 patients in Australia collected up to 18 months after ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

COVID-19 vaccine DNA contamination claims aren't new, but have resurfaced in the wake of a Canadian study that some ...

The Novavax vaccine targets the JN ... The Therapeutic Goods Administration, Australia’s equivalent of the FDA, recently addressed this misinformation, explaining that the reports that claim ...

Opus IVStm, the global leader in intelligent vehicle support, is excited to unveil IVS Mobile, an advanced mobile diagnostic app designed to deliver OEM-level diagnostics and expert support for ...

Caesarstone Ltd. , a leading developer and manufacturer of high-quality engineered surfaces, today announced that it will release its earnings results for the third quarter ended September 30, 2024 on ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

The market expects Novavax (NVAX) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus ...